Correlation Between Allovir and Mink Therapeutics

Can any of the company-specific risk be diversified away by investing in both Allovir and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allovir and Mink Therapeutics, you can compare the effects of market volatilities on Allovir and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and Mink Therapeutics.

Diversification Opportunities for Allovir and Mink Therapeutics

0.28

Correlation Coefficient

Allovir  Mink Therapeutics

Modest diversification

The 3 months correlation between Allovir and Mink is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Allovir i.e., Allovir and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Allovir and Mink Therapeutics

Given the investment horizon of 90 days Allovir is expected to under-perform the Mink Therapeutics. In addition to that, Allovir is 3.14 times more volatile than Mink Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Mink Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest  75.00  in Mink Therapeutics on September 17, 2024 and sell it today you would lose (13.40) from holding Mink Therapeutics or give up 17.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Allovir  vs.  Mink Therapeutics

Allovir

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Allovir and Mink Therapeutics

The main advantage of trading using opposite Allovir and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.

The idea behind Allovir and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.